Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,578
archived clinical trials in
Skin and Soft Tissue Infections

Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Fletcher Allen Health Care
mi
from
Burlington, VT
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Dermatology and Laser Center NW
mi
from
Bellingham, WA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Dermatology and Laser Center NW
mi
from
Bellingham, WA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Premier Clinical Research
mi
from
Seattle, WA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Premier Clinical Research
mi
from
Seattle, WA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Madison Skin & Research, Inc.
mi
from
Madison, WI
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Madison Skin & Research, Inc.
mi
from
Madison, WI
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
George Washington University Medical Faculty Associates
mi
from
Washington, D.C.,
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
George Washington University Medical Faculty Associates
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Washington University Dermatology Research
mi
from
Saint Louis, MO
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Washington University Dermatology Research
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Academy of Clinical Research
mi
from
Arlington, TX
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Academy of Clinical Research
mi
from
Arlington, TX
Click here to add this to my saved trials
Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa
A Phase 2B, Multi-center, Randomized, Double-Blind, Vehicle Controlled Study of the Effectiveness and Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
Status: Enrolling
Updated:  10/10/2017
Stanford University School of Medicine
mi
from
Palo Alto, CA
Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa
A Phase 2B, Multi-center, Randomized, Double-Blind, Vehicle Controlled Study of the Effectiveness and Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
Status: Enrolling
Updated: 10/10/2017
Stanford University School of Medicine
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa
A Phase 2B, Multi-center, Randomized, Double-Blind, Vehicle Controlled Study of the Effectiveness and Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
Status: Enrolling
Updated:  10/10/2017
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa
A Phase 2B, Multi-center, Randomized, Double-Blind, Vehicle Controlled Study of the Effectiveness and Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
Status: Enrolling
Updated: 10/10/2017
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa
A Phase 2B, Multi-center, Randomized, Double-Blind, Vehicle Controlled Study of the Effectiveness and Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
Status: Enrolling
Updated:  10/10/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa
A Phase 2B, Multi-center, Randomized, Double-Blind, Vehicle Controlled Study of the Effectiveness and Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
Status: Enrolling
Updated: 10/10/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa
A Phase 2B, Multi-center, Randomized, Double-Blind, Vehicle Controlled Study of the Effectiveness and Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
Status: Enrolling
Updated:  10/10/2017
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa
A Phase 2B, Multi-center, Randomized, Double-Blind, Vehicle Controlled Study of the Effectiveness and Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
Status: Enrolling
Updated: 10/10/2017
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa
A Phase 2B, Multi-center, Randomized, Double-Blind, Vehicle Controlled Study of the Effectiveness and Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
Status: Enrolling
Updated:  10/10/2017
Texas Dermatology and Laser Specialists
mi
from
San Antonio, TX
Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa
A Phase 2B, Multi-center, Randomized, Double-Blind, Vehicle Controlled Study of the Effectiveness and Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
Status: Enrolling
Updated: 10/10/2017
Texas Dermatology and Laser Specialists
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa
A Phase 2B, Multi-center, Randomized, Double-Blind, Vehicle Controlled Study of the Effectiveness and Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
Status: Enrolling
Updated:  10/10/2017
Seattle Children's Hospital
mi
from
Seattle, WA
Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa
A Phase 2B, Multi-center, Randomized, Double-Blind, Vehicle Controlled Study of the Effectiveness and Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
Status: Enrolling
Updated: 10/10/2017
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa
A Phase 2B, Multi-center, Randomized, Double-Blind, Vehicle Controlled Study of the Effectiveness and Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
Status: Enrolling
Updated:  10/10/2017
Hackensack University Medical Center
mi
from
Hackensack, NJ
Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa
A Phase 2B, Multi-center, Randomized, Double-Blind, Vehicle Controlled Study of the Effectiveness and Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
Status: Enrolling
Updated: 10/10/2017
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma
Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma
Status: Enrolling
Updated:  10/24/2017
University of Michigan
mi
from
Ann Arbor, MI
Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma
Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma
Status: Enrolling
Updated: 10/24/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Use of Infliximab for the Treatment of Pemphigus Vulgaris
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Infliximab in Subjects With Pemphigus Vulgaris Receiving Prednisone
Status: Enrolling
Updated:  11/1/2017
Norris Cancer Center, University of Southern California
mi
from
Los Angeles, CA
Use of Infliximab for the Treatment of Pemphigus Vulgaris
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Infliximab in Subjects With Pemphigus Vulgaris Receiving Prednisone
Status: Enrolling
Updated: 11/1/2017
Norris Cancer Center, University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Use of Infliximab for the Treatment of Pemphigus Vulgaris
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Infliximab in Subjects With Pemphigus Vulgaris Receiving Prednisone
Status: Enrolling
Updated:  11/1/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Use of Infliximab for the Treatment of Pemphigus Vulgaris
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Infliximab in Subjects With Pemphigus Vulgaris Receiving Prednisone
Status: Enrolling
Updated: 11/1/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Use of Infliximab for the Treatment of Pemphigus Vulgaris
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Infliximab in Subjects With Pemphigus Vulgaris Receiving Prednisone
Status: Enrolling
Updated:  11/1/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Use of Infliximab for the Treatment of Pemphigus Vulgaris
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Infliximab in Subjects With Pemphigus Vulgaris Receiving Prednisone
Status: Enrolling
Updated: 11/1/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Use of Infliximab for the Treatment of Pemphigus Vulgaris
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Infliximab in Subjects With Pemphigus Vulgaris Receiving Prednisone
Status: Enrolling
Updated:  11/1/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Use of Infliximab for the Treatment of Pemphigus Vulgaris
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Infliximab in Subjects With Pemphigus Vulgaris Receiving Prednisone
Status: Enrolling
Updated: 11/1/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, 3-Period Crossover Study to Evaluate the Efficacy and Safety of Recombinant Human C1 Inhibitor in the Prophylaxis of Angioedema Attacks in Patients With Hereditary Angioedema (HAE)
Status: Enrolling
Updated:  11/7/2017
University of South Florida - Asthma, Allergy and Immunology Clinical Research Unit
mi
from
Tampa, FL
A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, 3-Period Crossover Study to Evaluate the Efficacy and Safety of Recombinant Human C1 Inhibitor in the Prophylaxis of Angioedema Attacks in Patients With Hereditary Angioedema (HAE)
Status: Enrolling
Updated: 11/7/2017
University of South Florida - Asthma, Allergy and Immunology Clinical Research Unit
mi
from
Tampa, FL
Click here to add this to my saved trials
A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, 3-Period Crossover Study to Evaluate the Efficacy and Safety of Recombinant Human C1 Inhibitor in the Prophylaxis of Angioedema Attacks in Patients With Hereditary Angioedema (HAE)
Status: Enrolling
Updated:  11/7/2017
University of South Florida - Asthma, Allergy and Immunology Clinical Research Unit
mi
from
Tampa, FL
A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, 3-Period Crossover Study to Evaluate the Efficacy and Safety of Recombinant Human C1 Inhibitor in the Prophylaxis of Angioedema Attacks in Patients With Hereditary Angioedema (HAE)
Status: Enrolling
Updated: 11/7/2017
University of South Florida - Asthma, Allergy and Immunology Clinical Research Unit
mi
from
Tampa, FL
Click here to add this to my saved trials
A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, 3-Period Crossover Study to Evaluate the Efficacy and Safety of Recombinant Human C1 Inhibitor in the Prophylaxis of Angioedema Attacks in Patients With Hereditary Angioedema (HAE)
Status: Enrolling
Updated:  11/7/2017
Baker Allergy, Asthma and Dermatology Research Center
mi
from
Lake Oswego, OR
A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, 3-Period Crossover Study to Evaluate the Efficacy and Safety of Recombinant Human C1 Inhibitor in the Prophylaxis of Angioedema Attacks in Patients With Hereditary Angioedema (HAE)
Status: Enrolling
Updated: 11/7/2017
Baker Allergy, Asthma and Dermatology Research Center
mi
from
Lake Oswego, OR
Click here to add this to my saved trials
A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, 3-Period Crossover Study to Evaluate the Efficacy and Safety of Recombinant Human C1 Inhibitor in the Prophylaxis of Angioedema Attacks in Patients With Hereditary Angioedema (HAE)
Status: Enrolling
Updated:  11/7/2017
Ottawa Allergy Research Corp
mi
from
Ottawa,
A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, 3-Period Crossover Study to Evaluate the Efficacy and Safety of Recombinant Human C1 Inhibitor in the Prophylaxis of Angioedema Attacks in Patients With Hereditary Angioedema (HAE)
Status: Enrolling
Updated: 11/7/2017
Ottawa Allergy Research Corp
mi
from
Ottawa,
Click here to add this to my saved trials
A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, 3-Period Crossover Study to Evaluate the Efficacy and Safety of Recombinant Human C1 Inhibitor in the Prophylaxis of Angioedema Attacks in Patients With Hereditary Angioedema (HAE)
Status: Enrolling
Updated:  11/7/2017
Washington University Division of Allergy and Immunology
mi
from
Saint Louis, MO
A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, 3-Period Crossover Study to Evaluate the Efficacy and Safety of Recombinant Human C1 Inhibitor in the Prophylaxis of Angioedema Attacks in Patients With Hereditary Angioedema (HAE)
Status: Enrolling
Updated: 11/7/2017
Washington University Division of Allergy and Immunology
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy Women
Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy Women
Status: Enrolling
Updated:  11/15/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy Women
Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy Women
Status: Enrolling
Updated: 11/15/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections
Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute S. Aureus Skin and Skin Structure Infections in Patients With Comorbid Conditions: A Randomized Trial
Status: Enrolling
Updated:  11/16/2017
Grady Memorial Hospital
mi
from
Atlanta, GA
Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections
Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute S. Aureus Skin and Skin Structure Infections in Patients With Comorbid Conditions: A Randomized Trial
Status: Enrolling
Updated: 11/16/2017
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections
Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute S. Aureus Skin and Skin Structure Infections in Patients With Comorbid Conditions: A Randomized Trial
Status: Enrolling
Updated:  11/16/2017
University of Chicago Medical Center
mi
from
Chicago, IL
Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections
Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute S. Aureus Skin and Skin Structure Infections in Patients With Comorbid Conditions: A Randomized Trial
Status: Enrolling
Updated: 11/16/2017
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa
Allogeneic Hematopoietic Cell Transplantation to Correct the Biochemical Defect and Create Tolerance to Donor Tissue in Subjects With Epidermolysis Bullosa
Status: Enrolling
Updated:  12/3/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa
Allogeneic Hematopoietic Cell Transplantation to Correct the Biochemical Defect and Create Tolerance to Donor Tissue in Subjects With Epidermolysis Bullosa
Status: Enrolling
Updated: 12/3/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin
Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin
Status: Enrolling
Updated:  12/4/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin
Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin
Status: Enrolling
Updated: 12/4/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis
A Study to Evaluate the Efficacy and Safety of HAT01H, a Novel Topical Therapeutic: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/14/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis
A Study to Evaluate the Efficacy and Safety of HAT01H, a Novel Topical Therapeutic: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/14/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of Alwextin® Cream in Treating Epidermolysis Bullosa
Open-label, Pilot Study to Investigate the Safety and Tolerability of Alwextin 3.0% Cream in the Treatment of Epidermolysis Bullosa
Status: Enrolling
Updated:  12/20/2017
Robert and Ann Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Study of Alwextin® Cream in Treating Epidermolysis Bullosa
Open-label, Pilot Study to Investigate the Safety and Tolerability of Alwextin 3.0% Cream in the Treatment of Epidermolysis Bullosa
Status: Enrolling
Updated: 12/20/2017
Robert and Ann Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
Patient and Caregiver Quality of Life in the Treatment of Atopic Dermatitis in Pediatric Patients: a Comparison Between a General Pediatric Practice and a Pediatric Dermatology Practice
Status: Enrolling
Updated:  1/9/2018
Yale Dermatology Associates
mi
from
New Haven, CT
A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
Patient and Caregiver Quality of Life in the Treatment of Atopic Dermatitis in Pediatric Patients: a Comparison Between a General Pediatric Practice and a Pediatric Dermatology Practice
Status: Enrolling
Updated: 1/9/2018
Yale Dermatology Associates
mi
from
New Haven, CT
Click here to add this to my saved trials
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated:  1/11/2018
Wound Care Center, Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated: 1/11/2018
Wound Care Center, Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Click here to add this to my saved trials
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated:  1/11/2018
Comprehensive Wound Healing Center and Hyperbarics
mi
from
Lake Success, NY
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated: 1/11/2018
Comprehensive Wound Healing Center and Hyperbarics
mi
from
Lake Success, NY
Click here to add this to my saved trials
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated:  1/11/2018
Total Foot Care
mi
from
Cleveland, OH
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated: 1/11/2018
Total Foot Care
mi
from
Cleveland, OH
Click here to add this to my saved trials
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated:  1/11/2018
Heritage Valley Health System
mi
from
Beaver, PA
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated: 1/11/2018
Heritage Valley Health System
mi
from
Beaver, PA
Click here to add this to my saved trials
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated:  1/11/2018
Sunnyside Foot and Ankle
mi
from
Idaho Falls, ID
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated: 1/11/2018
Sunnyside Foot and Ankle
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated:  1/11/2018
Good Samaritan Wound Care Center
mi
from
Bakersfield, CA
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds
Status: Enrolling
Updated: 1/11/2018
Good Samaritan Wound Care Center
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated:  1/22/2018
Little Rock Allergry and Asthma Clinical Research Center
mi
from
Little Rock, AR
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated: 1/22/2018
Little Rock Allergry and Asthma Clinical Research Center
mi
from
Little Rock, AR
Click here to add this to my saved trials
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated:  1/22/2018
Sunrise Clinical Research
mi
from
Bell Gardens, CA
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated: 1/22/2018
Sunrise Clinical Research
mi
from
Bell Gardens, CA
Click here to add this to my saved trials
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated:  1/22/2018
Allergy & Asthma Institute of the Valley
mi
from
Granada Hills, CA
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated: 1/22/2018
Allergy & Asthma Institute of the Valley
mi
from
Granada Hills, CA
Click here to add this to my saved trials
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated:  1/22/2018
Unidversity of California, Los Angeles David Geffen School of Medicine
mi
from
Los Angeles, CA
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated: 1/22/2018
Unidversity of California, Los Angeles David Geffen School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated:  1/22/2018
705 West LaVeta
mi
from
Orange, CA
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated: 1/22/2018
705 West LaVeta
mi
from
Orange, CA
Click here to add this to my saved trials
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated:  1/22/2018
Allergy & Asthma Clinical Research, Inc.
mi
from
Walnut Creek, CA
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated: 1/22/2018
Allergy & Asthma Clinical Research, Inc.
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated:  1/22/2018
Center for Allergy, Asthma and Immunology
mi
from
Waterbury, CT
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated: 1/22/2018
Center for Allergy, Asthma and Immunology
mi
from
Waterbury, CT
Click here to add this to my saved trials
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated:  1/22/2018
University of South Florida Asthma
mi
from
Tampa, FL
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated: 1/22/2018
University of South Florida Asthma
mi
from
Tampa, FL
Click here to add this to my saved trials
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated:  1/22/2018
Brookstone Clinical Research Center
mi
from
Columbus, GA
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated: 1/22/2018
Brookstone Clinical Research Center
mi
from
Columbus, GA
Click here to add this to my saved trials
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated:  1/22/2018
University Consultants in Allergry and Immunology
mi
from
Chicago, IL
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated: 1/22/2018
University Consultants in Allergry and Immunology
mi
from
Chicago, IL
Click here to add this to my saved trials
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated:  1/22/2018
Deaconess Clinic Downtown
mi
from
Evansville, IN
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
A Phase 4, Long-Term Observational Safety Study to Evaluate Immunogenicity and Hypersensitivity With Exposure to KALBITOR (Ecallantide) for the Treatment of Acute Attacks of HAE
Status: Enrolling
Updated: 1/22/2018
Deaconess Clinic Downtown
mi
from
Evansville, IN
Click here to add this to my saved trials